These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16807729)

  • 1. Population clinical pharmacology of children: modelling covariate effects.
    Anderson BJ; Allegaert K; Holford NH
    Eur J Pediatr; 2006 Dec; 165(12):819-29. PubMed ID: 16807729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population clinical pharmacology of children: general principles.
    Anderson BJ; Allegaert K; Holford NH
    Eur J Pediatr; 2006 Nov; 165(11):741-6. PubMed ID: 16807730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic investigation of actinomycin-D in children and young adults.
    Mondick JT; Gibiansky L; Gastonguay MR; Skolnik JM; Cole M; Veal GJ; Boddy AV; Adamson PC; Barrett JS
    J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and size are the major covariates for prediction of levobupivacaine clearance in children.
    Chalkiadis GA; Anderson BJ
    Paediatr Anaesth; 2006 Mar; 16(3):275-82. PubMed ID: 16490091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
    Fanta S; Jönsson S; Backman JT; Karlsson MO; Hoppu K
    Br J Clin Pharmacol; 2007 Dec; 64(6):772-84. PubMed ID: 17662086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic standard for babies and adults.
    Holford N; Heo YA; Anderson B
    J Pharm Sci; 2013 Sep; 102(9):2941-52. PubMed ID: 23650116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children.
    Trame MN; Bergstrand M; Karlsson MO; Boos J; Hempel G
    Clin Cancer Res; 2011 Nov; 17(21):6867-77. PubMed ID: 21918171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amikacin population pharmacokinetics among paediatric burn patients.
    Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
    Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized dosing regimens in children based on population PKPD modelling: are we ready for it?
    Knibbe CA; Danhof M
    Int J Pharm; 2011 Aug; 415(1-2):9-14. PubMed ID: 21376791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.
    Zhao W; Zhang D; Storme T; Baruchel A; Declèves X; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2015 Nov; 80(5):1197-207. PubMed ID: 26138279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors.
    Panetta JC; Kirstein MN; Gajjar A; Nair G; Fouladi M; Heideman RL; Wilkinson M; Stewart CF
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):435-41. PubMed ID: 13680158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indexing glomerular filtration rate to suit children.
    Bird NJ; Henderson BL; Lui D; Ballinger JR; Peters AM
    J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis.
    Zühlsdorf M; Bhattaram VA; Campioni M; Krösser S; Derendorf H; Kovar A
    J Clin Pharmacol; 2014 Dec; 54(12):1391-9. PubMed ID: 24911832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of topotecan in pediatric cancer patients.
    Schaiquevich P; Panetta JC; Iacono LC; Freeman BB; Santana VM; Gajjar A; Stewart CF
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6703-11. PubMed ID: 18006771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric pharmacology in the first year of life.
    Sumpter A; Anderson BJ
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):469-75. PubMed ID: 19593898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
    Hawwa AF; Collier PS; Millership JS; McCarthy A; Dempsey S; Cairns C; McElnay JC
    Br J Clin Pharmacol; 2008 Dec; 66(6):826-37. PubMed ID: 18823306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.